Promoting cardiac cell differentiation
AssigneeFlorid Atlantic University
InventorsLarry F. Lemanski, Chi Zhang
Life of this patent
Estimating the term…
Abstract
Compositions and methods for inducing a cardiac muscle phenotype, such as rhythmic contraction and formation of myofibrils, in a cell are described. Disclosed are nucleic acids encoding myofibrillogenesis-inducing RNA (MIR) molecules, RNA molecules (MIR) and RNA-binding proteins that bind to MIR to induce myofibrillogenesis and vectors comprising these nucleic acids. Also included is a method of promoting cardiac muscle differentiation using these compositions.
Claims24
A purified nucleic acid comprising a nucleotide sequence that encodes a myofibrillogeneis-inducing RNA (MIR) molecule having at least one functional activity of a native MIR molecule.
A purified myofibrillogenesis-inducing RNA (MIR) molecule comprising a ribonucleic acid sequence is a complement of a deoxyribonucleic acid sequence that encodes a myofibrillogeneis-inducing RNA (MIR) molecule having at least one functional activity of a native MIR molecule, wherein said deoxyribonucleic acid sequence encodes a polyribonucleic acid that is between about 167 and about 620 nucleotides in length.
A vector comprising a purified nucleic acid that encodes a myofibrillogeneis-inducing RNA (MIR) molecule having at least one functional activity of a native MIR molecule.
A method of inducing a cardiac muscle phenotype in a cell, said method comprising the steps of:
- a) providing a cell comprising at least one MIR-binding protein;
- and
- b) contacting said cell with at least one MIR molecule that specifically binds to said at least one MIR-binding protein, in an amount sufficient to induce a cardiac muscle phenotype in said cell.
Dependencies are inferred from the claim text.